Results 21 to 30 of about 12,137,319 (407)

Multifaceted Roles of Ferroptosis in Lung Diseases

Frontiers in Molecular Biosciences, 2022
Ferroptosis is a distinct type of programmed cell death (PCD) that depends on iron and is characterized by the accumulation of intracellular iron, exhaustion of glutathione, deactivation of glutathione peroxidase, and promotion of lipid peroxidation ...
Yi Li, Ying Yang, Yongfeng Yang
semanticscholar   +1 more source

Nontuberculous Mycobacterial Lung Disease in the Patients with Cystic Fibrosis—A Challenging Diagnostic Problem

Diagnostics, 2022
Background: Cystic fibrosis (CF) is an autosomal, recessive genetic disorder, caused by a mutation in the cystic fibrosis transmembrane conductance receptor regulator (CFTR) gene.
Dorota Wyrostkiewicz, Lucyna Opoka, Dorota Filipczak, Ewa Jankowska, Wojciech Skorupa, Ewa Augustynowicz-Kopeć, Monika Szturmowicz   +6 more
doaj   +1 more source

Factors Predictive for Immunomodulatory Therapy Response and Survival in Patients with Hypersensitivity Pneumonitis—Retrospective Cohort Analysis

Diagnostics, 2022
Hypersensitivity pneumonitis (HP) is one of the interstitial lung diseases with clearly established diagnostic criteria. Nevertheless, pharmacologic treatment recommendations are still lacking. Most specialists use steroids as first-line drugs, sometimes
Katarzyna B. Lewandowska, Inga Barańska, Małgorzata Sobiecka, Piotr Radwan-Rohrenschef, Małgorzata Dybowska, Monika Franczuk, Adriana Roży, Agnieszka Skoczylas, Iwona Bestry, Jan Kuś, Witold Z. Tomkowski, Monika Szturmowicz   +11 more
doaj   +1 more source

Pulmonary amyloidosis mimicking interstitial lung disease and malignancy - A case series with a review of a pulmonary patterns

Respiratory Medicine Case Reports, 2021
Background: Amyloidosis is an uncommon condition, which results from accumulation of misfolded extracellular insoluble protein in tissues and organs of the body, causing its damage and dysfunction.
Katarzyna Zimna, Małgorzata Sobiecka, Renata Langfort, Katarzyna Błasińska, Witold Z. Tomkowski   +4 more
doaj   +1 more source

Scleroderma lung disease [PDF]

European Respiratory Review, 2013
Systemic sclerosis (SSc) is a systemic autoimmune disease that is characterised by endothelial dysfunction resulting in a small-vessel vasculopathy, fibroblast dysfunction with resultant excessive collagen production and fibrosis, and immunological abnormalities.
Joshua J. Solomon, Amy L. Olson, Aryeh Fischer, Todd Bull, Kevin K. Brown, Ganesh Raghu   +5 more
openaire   +3 more sources

Nintedanib: A Review in Fibrotic Interstitial Lung Diseases

Drugs, 2021
Progressive fibrosing interstitial lung diseases (ILDs) involve similar pathophysiological processes, indicating the potential for common approaches to treatment.
Yvette N. Lamb
semanticscholar   +1 more source

Tuberculous Pericarditis—Own Experiences and Recent Recommendations

Diagnostics, 2022
Tuberculous pericarditis (TBP) accounts for 1% of all forms of tuberculosis and for 1–2% of extrapulmonary tuberculosis. In endemic regions, TBP accounts for 50–90% of effusive pericarditis; in non-endemic, it only accounts for 4%.
Małgorzata Dybowska, Katarzyna Błasińska, Juliusz Gątarek, Magdalena Klatt, Ewa Augustynowicz-Kopeć, Witold Tomkowski, Monika Szturmowicz   +6 more
doaj   +1 more source

Recent applications and strategies in nanotechnology for lung diseases

Nano Reseach, 2021
Lung diseases, including COVID-19 and lung cancers, is a huge threat to human health. However, for the treatment and diagnosis of various lung diseases, such as pneumonia, asthma, cancer, and pulmonary tuberculosis, are becoming increasingly challenging.
Wenhao Zhong, Xinyu Zhang, Yunxin Zeng, D. Lin, Jun Wu   +4 more
semanticscholar   +1 more source

Etiologic Classification of Diffuse Parenchymal (Interstitial) Lung Diseases

Journal of Clinical Medicine, 2022
Interstitial lung diseases (ILD) or diffuse parenchymal lung diseases (DPLD) comprise a large number of disorders. Disease definition and classification allow advanced and personalized judgements on clinical disease, risks for genetic or environmental ...
M. Griese
semanticscholar   +1 more source

Pulmonary Hypertension in the Course of Interstitial Lung Diseases—A Personalised Approach Is Needed to Identify a Dominant Cause and Provide an Effective Therapy

Diagnostics, 2023
The prevalence of pulmonary hypertension (PH) complicating interstitial lung diseases (ILDs) is 3.5–15% at an early stage, and up to 90% in ILD patients listed for lung transplantation.
Aneta Kacprzak, Witold Tomkowski, Monika Szturmowicz   +2 more
doaj   +1 more source